Table 2. Diagnostic b and y Ions of Phosphorylated IR Peptidesb.
| product | phosphorylation site | tR, min | precursor [M + 3H]3+ | b4 | b5 | y3 | y4 | y5 | immonium ion |
|---|---|---|---|---|---|---|---|---|---|
| IR0 | 5.99 | 541.6 | X | X | X | X | X | ||
| IR0 + p | Tyr9 | 5.89 | 568.3 | X | X | X | X/p | X/p | pY |
| IR0 + 2p | mostly Tyr9 + Tyr10 | 5.65 | 594.9 | X | X/p | X/p | p/2p | p/2p | pY |
| IR0 + 3p | Tyr5 + Tyr9 + Tyr10 | 5.19 | 621.6 | X | X/p | p | p/2p | p/2p | pY |
| IR1 | 5.71 | 546.6 | X | X | X | X | X | ||
| IR1 + p | Tyr9 | 5.60 | 573.6 | X | X | X | X/p | X/p | pY |
| IR1 + 2p | mostly Tyr9 + Tyr10 | 5.30 | 600.2 | X | X | p | p/2p | p/2p | pY and pl-DOPA |
| IR1 + 3p | Tyr5 + Tyr9 + Tyr10 | 5.17 | 626.9 | X | X/p | p | 2p | 2p | pY and pl-DOPA |
| IR2 | 5.50 | 552.3 | X | X | X | X | X | ||
| IR2 + p | Tyr9 | 5.37 | 578.9 | X | X | X | X/p | X/p | pY |
| IR2 + 2p | mostly Tyr9 + Tyr10 | 5.30 | 605.6 | X | X | X/p | p/2p | 2p | pY and pl-DOPA |
| IR2 + 3p | Tyr5 + Tyr9 + Tyr10 | 5.15 | 632.2 | X | p | a | 2p | 2p | |
| IR3 | 5.24 | 557.6 | X | X | X | X | X | ||
| IR3 + p | Tyr9 | 5.30 | 584.2 | X | X | X | X/p | X/p | pl-DOPA |
| IR3 + 2p | mostly Tyr9 + Tyr10 | 5.27 | 610.9 | X | X/p | X/p | p/2p | X/p/2p | pl-DOPA |
| IR3 + 3p | Tyr5 + Tyr9 + Tyr10 | 5.13 | 637.6 | X | p | p | p/2p | p/2p | pl-DOPA |
Not observed.
Nonphosphorylated fragments are marked with X, singly phosphorylated fragments with p, and doubly phosphorylated fragments with 2p. Present phosphotyrosine immonium ion is marked as pY and phospho-l-DOPA immonium ion as pl-DOPA. Accurate masses, relative abundances, and mass accuracies are provided in Table S5.